SEI Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-18,613
Closed -$62K 2589
2020
Q3
$62K Sell
18,613
-766
-4% -$3.26K ﹤0.01% 2364
2020
Q2
$76K Sell
19,379
-325
-2% -$1.46K ﹤0.01% 2340
2020
Q1
$67K Sell
19,704
-89,099
-82% -$438K ﹤0.01% 2283
2019
Q4
$684K Buy
+108,803
New +$640K ﹤0.01% 1801
2019
Q3
Sell
-96,054
Closed -$447K 2479
2019
Q2
$447K Sell
96,054
-16,795
-15% -$78.2K ﹤0.01% 1940
2019
Q1
$598K Buy
+112,849
New +$515K ﹤0.01% 1804
2016
Q4
Sell
-25,569
Closed -$69K 3203
2016
Q3
$69K Buy
25,569
+10,902
+74% +$27.7K ﹤0.01% 1976
2016
Q2
$35K Buy
14,667
+10,982
+298% +$30.3K ﹤0.01% 2029
2016
Q1
$12K Sell
3,685
-327,104
-99% -$1.21M ﹤0.01% 2162
2015
Q4
$1.58M Buy
330,789
+233,519
+240% +$1.32M 0.01% 1084
2015
Q3
$541K Buy
97,270
+93,481
+2,467% +$690K 0.01% 1266
2015
Q2
$30K Sell
3,789
-4,128
-52% -$35.5K ﹤0.01% 1765
2015
Q1
$82K Sell
7,917
-4,836
-38% -$66.1K ﹤0.01% 1595
2014
Q4
$152K Buy
+12,753
New +$194K ﹤0.01% 1485

Other funds holding BDSI

SEI Investments's BDSI Position: Q4 2020 in Review

SEI Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 18,613 shares — an estimated $62K sold.

SEI Investments first reported a position in BDSI in Q4 2014 and held it in 14 quarters. The position peaked at $1.58M in Q4 2015. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • SEI Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
  • SEI Investments sold 18,613 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $62K.
  • SEI Investments first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 14 quarters.
  • SEI Investments's BioDelivery Sciences International, Inc. position peaked at $1.58M in Q4 2015.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.